SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-032160
Filing Date
2024-02-12
Accepted
2024-02-12 16:34:08
Documents
14
Period of Report
2024-02-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d764004d8k.htm   iXBRL 8-K 24286
  Complete submission text file 0001193125-24-032160.txt   146140

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alvr-20240209.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20240209_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20240209_pre.xml EX-101.PRE 11258
15 EXTRACTED XBRL INSTANCE DOCUMENT d764004d8k_htm.xml XML 3620
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 24620549
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)